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Aim: The main purpose of this study is to determine the current status of long-term follow-up (LTFU) for childhood cancer survivors
and the challenges of LTFU for pediatric cancer survivors at pediatric oncology institutions in Turkey.
Material and methods: A questionnaire was e-mailed to the directors of 33 pediatric oncology centers (POCs) registered in the Turkish
Pediatric Oncology Group (TPOG). Of these 33 active TPOG institutions, 21 participated in the study and returned their completed
questionnaires.
Results: Only 1 of the 21 participating centers had a separate LTFU clinic. The remaining centers provided LTFU care for childhood
cancer survivors at the pediatric oncology outpatient clinic. Of these centers, 17 (80.9%) reported difficulty in transition from the
pediatric clinic to the adult clinic, 14 (66.6%) reported insufficient care providers, and 12 (57.1%) reported insufficient time and
transportation problems. As neglected late effects, 16 (76.1%) centers reported psychosocial and getty job problems and 11 (52.3%)
reported sexual and cognitive problems. None of the centers had their own LTFU guidelines for their daily LTFU practice.
Conclusion: This study was the first to gain an overview of the needs of POCs and the gaps in survivorship services in Turkey. The
results from this study will help to develop a national health care system and national guidelines for pediatric cancer survivors.
Key words: Long term follow-up, survivorship, pediatric oncology, Turkey
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1. Introduction
As a result of advances in modern multidisciplinary
treatment approaches and supportive care, the population
of childhood cancer survivors has increased, with a
survival rate of 80%. Although treatment regimens have
been optimized to reduce immediate and late effects,
long-term survivors of childhood cancers are at risk for
treatment-related late effects throughout their lifespan.
Approximately 73% of long-term survivors will have at
least 1 chronic health problem within 30 years of their
diagnosis, in which case, 42% are expected to have lifethreatening conditions. The risk of developing these severe
conditions is 8 times greater when compared to their
siblings with no cancer [1–3].
Since the risk of many serious health problems can be
reduced by prevention or early detection, survivors require
systematic plans for periodic risk-adapted surveillance
and prevention. In many developed countries, in response
to a growing understanding of the potential treatmentrelated late effects, national long-term follow-up (LTFU)
programs and guidelines have been developed for pediatric
cancer survivors over the past 3 decades [1,4,5].
Over the past 20 years, Turkey has successfully
introduced changes in key health system functions
of organizations and governance, financing, resource
management, and service delivery [6–8]. In parallel to the
recent developments, the number of pediatric oncologists
who were educated in developed centers has increased,
and the procedures seen in multidisciplinary therapeutic
approaches to childhood cancers has increased as well.
Hence, the survival rates have increased dramatically
[9,10]. As a result of the increase in cancer survival rates,
it is crucial to identify current survivorship practices at
pediatric oncology centers (POCs) across Turkey. There
are no collective multicenter data related LTFU for
childhood cancer survivors in Turkey. Some hospitalbased late effects or secondary cancer publication data are
available to date from Turkey [11–14]. The main purpose
of this study was to determine the current status of LTFU
for childhood cancer survivors and the challenges of
LTFU for pediatric cancer survivors at pediatric oncology
institutions in Turkey.
2. Methods
The study was conducted between October 2016 and
February 2017. The descriptive survey instrument was
developed by the investigators. The survey content and
format were based on prior international surveys and
guidelines [5,15–18]. A questionnaire was e-mailed to the
directors of 33 POCs registered in the Turkish Pediatric
Oncology Group (TPOG). Directors who did not respond
to the first e-mail were sent a subsequent e-mail 4 weeks
later. The surveys were collected over a period of 2 months.

The questionnaire was organized with the following
sections:
1. Description of the centers: historical time, yearly
new patient number, follow-up period, and electronic
medical record system.
2. Methods of follow-up for late effects: current clinical
practice, determining the methods of LTFU, problems that
cannot be evaluated in follow-up, and challenges for LTFU.
3. Transition problems of survivors to adult programs.
4. Educational problems of the hematology/oncology
fellows (HOFs) about LTFU.
5. Suggestions for improvement of LTFU.
2.1. Statistics
Descriptive analyses were performed for all of the
quantitative data and listed with frequencies and
percentages for the categorical variables and medians and
ranges for the quantitative variables. All statistical analyses
were calculated using SPSS Statistics for Windows 17.0
(SPSS Inc., Chicago, IL, USA).
3. Results
3.1. Participating POCs
Of the 33 active TPOG institutions, 21 participated in the
study and returned their completed questionnaires, with a
final survey response rate of 63%. All of the POCs serv the
health care needs of children, from infancy to adolescence.
The POCs varied in terms of their size/number of beds
and experience/historical time period. Table 1 displays the
characteristics of the 21 POCs analyzed in this study. The
median experience time as a POC and the median number
of yearly new cases were 23 years (2–50 years) and 68 (8–
300), respectively. Of the 21 centers that participated, 11
(52.3%) had an electronic record system, and 8 of these 11
centers had used a digital recording system since the year
2000. All of the POCs followed up the survivors annually.
All of the POCs reported that the minimum duration of
time that they cared for survivors was up to 18 years of age.
On the other hand 10 (47.6%) and 4 POCs (19%) reported
that this time was up to 25 years of age and to the end of
life, respectively. Only 1 center reported that they had a
separate LTFU clinic for survivors.
3.2. LTFU programs
All of the centers reported that they followed up childhood
cancer survivors. However, none of the centers used
standardized, risk-based, survivor-focused guidelines.
Of the centers, 8 reported that they usually recommend
screening programs irrespective of the risk for late effects,
and 13 used risk-based, but not standardized screening for
late effects. Only 1 of the 21 participating centers had a
separate LTFU clinic. This clinic was open 2 days a week.
The remaining centers provided LTFU care for childhood
cancer survivors at their pediatric oncology outpatient
clinics.
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Table 1. Characteristics of 21 Turkish POCs.
Median historical time (years)

23.3 (range: 2–50)

Median number of the newly diagnosed patients/ year

67.9 (range: 8–300)

Median number of beds

15 (range: 3–32)

Number of POCs that follow survivors until their 18th birthday

21

Number of POCs that follow survivors until their 25th birthday

10

Number of POCs that follow survivors until the end of their life

4

Number of the POCs that followed survivors yearly

21

Number of POCs with a specialized LTFU clinic

1

Number of POCs with electronic records

11

Median lost follow up percentages

12% (range: 1–50)

All of the POCs reported at least 1 neglected late
effect during LTFU. All of the POCs followed-up on
cardiotoxicity, secondary cancer, and kidney toxicity
with no problems. As for the neglected late effects, 16
(76.1%) POCs reported psychosocial and administrative
problems, 11 (52.3%) reported sexual and cognitive late
effects, 8 (38.1%) reported gonadal dysfunction, and 1
(4.7%) reported endocrinologic side effects. Details of the
neglected late effects during LTFU are presented in Table 2.
3.3. Barriers of LTFU
All of the POCs reported at least 1 challenge. Specifically,
17 (80.9%) POCs reported difficulty transitioning from
the pediatric to adult clinic, 14 (66.6%) reported a lack
of care providers, 12 (57.1%) reported a lack of time and
transportation problems, and 8 (38%) reported a lack

Table 2. Neglected late effects of survivors in Turkish POCs
during LTFU*.
Late effects

n

%

Psychological problems

16

76.1

Social problem (job, etc.)

16

76.1

Cognitive problems

11

52.3

Sexual dysfunction

11

52.3

School performance

11

52.3

Cosmetic problem

10

47.6

Oral health

9

42.8

Gonadal dysfunction

8

38.1

Genito-urinary problems

5

23.8

Neurological side effects

3

14.3

Ototoxicity

2

9.5

Endocrinologic side effects

1

4.7

*Some centers had more than one problem.
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of providing knowledge to patients. Table 3 shows the
barriers for LTFU.
All of the centers used the treatment summary report
of the patients for the transition from the pediatric to
adult center. This procedure was the routine transferring
procedure of patients in all of the centers. Only 5 centers
informed the adult departments about transferring by
verbal communication.
3.4. Barriers for teaching pediatric HOFs about LTFU
Of the 21 centers, 17 had pediatric hematology/oncology
fellowship training programs. Of those 17 POCs, 14 (66%)
reported that they had insufficient education for LTFU,
and 12 (85.7%) of those 14 centers asserted that the reason
for the insufficient education was a lack of specialized
LTFU clinics. Among the 9 centers out of a total 21 centers,
8 (57.1%) reported that the reason for the insufficient
education was insufficient care providers and time, while it
was a lack of education programs according to the 1 (7.1%)
center.
4. Discussion
Cancer is a chronic disease that can cause lasting impact
after treatment ends. As is the case for other middleincome countries, chronic diseases pose a major future
challenge for Turkey. Therefore, there is a need for health
policies that will confront this issue. Although the Ministry
of Health has started various programs for the prevention
and the control of chronic diseases, there is no routine
surveillance and there is insufficient data on pediatric
survivorship [19].
The TPOG and Turkish Pediatric Hematology
Association established a web-based cancer registry in
Turkey in 2002. Over the 14 years from 2002 to 2016, a total
of 21,478 pediatric cancer cases were recorded. Survival
rates for children have increased from 65% to 70% based
on the latest information [9,10]. Unfortunately, there are
no data about whether this large population has accessed
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Table 3. Barriers for Turkish POCs for the LTFU of pediatric cancer survivors.
Barriers

n

%

Lack of care providers

14

66.6

Lack of time

12

57.1

Financial problems of center

7

33.3

Lack of health insurance (after 18 years of age)

9

42.8

Transition problems of survivors from pediatric to adult clinics

12

57.1

Lack of providing knowledge to patients

8

38.1

LTFU services and the quality of the services available. The
current study is the first to report national data for LTFU
services in Turkey. The overall objective of this study was
to gain a better understanding of the current state of LTFU
in Turkey. The questionnaire survey was able to reach twothirds of the POCs, located in 8 cities, that followed up
most of the pediatric oncology patients in Turkey. Thus, the
findings reflected the latest results for Turkey. The results
of this study will help to improve the survivorship services
in Turkey via preparing a short guideline to standardized
care with an easy risk-adapted formula.
The most important finding of this study was that
pediatric cancer survivorship has not flourished in Turkey
because only 1 center reported having a separate LTFU
clinic. In the remaining 20 centers, LTFU was provided by
the pediatric oncologists in the outpatient clinics. There is
an urgent need for specialized LTFU clinics, where medical
and allied health professionals, such as social workers,
clinical psychologists, and rehabilitation specialists, work
in Turkey. Only 4 centers reported providing caring for
survivors until the end of their lives. However, the other
centers provided care for childhood cancer survivors
and patients younger than 30 years of age. In Turkey, the
relevant law, which was revised in 2018, states that diseases
that start in childhood and require diagnosis, treatment,
and follow-up through adulthood can be cared for and
followed up by pediatric subspecialists until the age of 23
[20].
This loss of survivors to the lack of follow-up means
that such patients will receive ongoing medical care from
a clinician other than a pediatric oncologist, and they will
not be monitored for late effects. Moreover, these responses
suggest inconsistency with legislation. In addition, about
half of the centers had no electronic medical records to
monitor the patients.
POCs have several challenges, and herein, 80.9% of the
POCs reported difficulties transitioning from the pediatric
to adult clinics, 66.6% reported a lack of health care
providers, and 57.1% reported a lack of time. The results of
the study reflected that one of the most important barriers
was insufficient healthcare system support that established

a multidisciplinary coordination of care between the
pediatric and adult medical subspecialists. Another factor
that promoted these challenges was the absence of a formal
adult follow-up program in Turkey. These barriers have
been reported repeatedly in the literature, to implement
survivorship care, even in developed countries with an
organized healthcare system [15,16,21–24].
In most developing countries, such as Turkey, common
practice is to focus on the monitoring of cancer recurrence
and symptoms directly related to the treatment. The
results herein showed that, generally, POCs do not provide
sufficient LTFU. All of the centers agreed on the necessity
of risk-based national guidelines for LTFU.
In addition, this study revealed that there were many
barriers in the process of teaching pediatric HOFs for
LTFU. The main barrier was the lack of specialized LTFU
clinics. Nathan et al. reported a lack of time for training to
learn about the late effects as the most significant barrier to
provide survivorship [17].
In many developed countries, in response to a growing
understanding of the potential treatment-related late
effects, national LTFU programs have been created
for pediatric cancer survivors over the past 3 decades.
These programs are influenced by political, economic,
sociocultural, and institutional factors. For developing
countries like Turkey, the process of providing care is
often weak and continuously changing. In Turkey, reforms
have focused on access to primary health care services
[6–8]. Unfortunately, there has been no improvement in
this area. In the current Turkish health care system, the
question of responsibility for the care of cancer survivors
among health care providers remains unclear.
How can these barriers be overcome? As members of
the TPOG, we know that we have to develop short and
long term solutions for these problems. After developing a
handy survivorship guideline according to the needs of the
centers, it will be important to share a national program
that determines specific information about what services
are provided, how they are provided, and by whom and
for whom they are provided. In 2005, family medicinecentered primary health-care services were developed in
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all provinces of Turkey [6]. In order to effectively manage
pediatric cancer survivors, it is necessary to ensure
communication between pediatric oncologists and family
physicians through treatment summaries and survivor
care plans. Financial, staff, and infrastructure support
is needed to establish such a program, thus cooperation
with politicians is needed. The role of the government
is to establish principles, and set the political agenda for
survivorship services. Even in developed countries, in
which LTFU systems that have been established long ago,
many difficulties in clinical practice have been reported.
Therefore, a simple and practical system should be
developed to address these barriers. The publication of
new guidelines after a workshop study with these centers
has been planned.
This study had several limitations. The main limitation
of this study was the self-reporting of the data by the
centers themselves. Another limitation was that the study
was conducted among POCs; hence, some patients with
leukemia might not have been included in this group

because they were followed up by pediatric hematology
centers. Furthermore, it was not possible to compare
the data with the one from other countries with similar
problems due to the limited literature. Despite these
limitations, this study was the first to gain an overview of
the needs of POCs and the gaps in survivorship services
in Turkey. The results from this study will help to develop
a national health care system and national guidelines for
pediatric cancer survivors.
In conclusion, reports from 21 POCs in Turkey, in 2017,
were reviewed and analyzed for survivorship practices.
Many of the barriers of survivorship care included issues
of access (access to what?), quality, and funding. These
barriers were similar to those identified for LTFU in other
developing countries and will establish the basis of the
planned LTFU guideline study.
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